Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A low Dicer expression is associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinoma.
Kawahara K, Nakayama H, Nagata M, Yoshida R, Hirosue A, Tanaka T, Nakagawa Y, Matsuoka Y, Kojima T, Takamune Y, Yoshitake Y, Hiraki A, Shinohara M. Kawahara K, et al. Among authors: nagata m. J Oral Pathol Med. 2014 May;43(5):350-6. doi: 10.1111/jop.12140. Epub 2013 Dec 10. J Oral Pathol Med. 2014. PMID: 24325353
IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma.
Matsuoka Y, Nakayama H, Yoshida R, Hirosue A, Nagata M, Tanaka T, Kawahara K, Sakata J, Arita H, Nakashima H, Shinriki S, Fukuma D, Ogi H, Hiraki A, Shinohara M, Toya R, Murakami R. Matsuoka Y, et al. Among authors: nagata m. Br J Cancer. 2016 Nov 8;115(10):1234-1244. doi: 10.1038/bjc.2016.327. Epub 2016 Oct 13. Br J Cancer. 2016. PMID: 27736845 Free PMC article.
Concurrent chemoradiotherapy with S-1 in patients with stage III-IV oral squamous cell carcinoma: A retrospective analysis of nodal classification based on the neck node level.
Murakami R, Semba A, Kawahara K, Matsuyama K, Hiraki A, Nagata M, Toya R, Yamashita Y, Oya N, Nakayama H. Murakami R, et al. Among authors: nagata m. Mol Clin Oncol. 2017 Jul;7(1):140-144. doi: 10.3892/mco.2017.1276. Epub 2017 May 29. Mol Clin Oncol. 2017. PMID: 28685092 Free PMC article.
FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
Arita H, Nagata M, Yoshida R, Matsuoka Y, Hirosue A, Kawahara K, Sakata J, Nakashima H, Kojima T, Toya R, Murakami R, Hiraki A, Shinohara M, Nakayama H. Arita H, et al. Among authors: nagata m. Tumour Biol. 2017 Oct;39(10):1010428317731771. doi: 10.1177/1010428317731771. Tumour Biol. 2017. PMID: 29072128 Free article.
BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene.
Yamamoto T, Hirosue A, Nakamoto M, Yoshida R, Sakata J, Matsuoka Y, Kawahara K, Nagao Y, Nagata M, Takahashi N, Hiraki A, Shinohara M, Nakao M, Saitoh N, Nakayama H. Yamamoto T, et al. Among authors: nagata m. Br J Cancer. 2020 Aug;123(4):580-590. doi: 10.1038/s41416-020-0907-6. Epub 2020 Jun 5. Br J Cancer. 2020. PMID: 32499570 Free PMC article.
Factors affecting volume change of myocutaneous flaps in oral cancer.
Hiraki A, Yamamoto T, Yoshida R, Nagata M, Kawahara K, Nakagawa Y, Matsuoka Y, Tanaka T, Hirosue A, Fukuma D, Ikebe T, Shinohara M, Nakayama H. Hiraki A, et al. Among authors: nagata m. Int J Oral Maxillofac Surg. 2016 Nov;45(11):1395-1399. doi: 10.1016/j.ijom.2016.04.014. Epub 2016 May 8. Int J Oral Maxillofac Surg. 2016. PMID: 27170618
2,388 results